1. An EUA for bamlanivimab-a monoclonal antibody for COVID-19;JAMA,2020
2. An EUA for bamlanivimab etesevimab for COVID-19;Med Lett Drugs Ther,2021
3. An EUA for casirivimab imdevimab for COVID-19;Med Lett Drugs Ther,2020
4. Jones BE, et al. LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection [preprint]. https://doi.org/10.1101/2020.09.30.318972 Posted on bioRxiv October 9, 2020
5. Coronavirus (COVID-19) update: FDA revokes emergency use authorization for monoclonal antibody bamlanivimab. News release. U.S. Food and Drug Administration; April 16, 2021. Accessed April 24, 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab